跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,570 条关于
“Tanabe Pharma America”
全部
13,570
临床试验
6,306
药物
1,182
机构
1,441
资讯
4,641
去年
Mitsubishi Tanabe Pharma America to Present Breakthrough Neurodegenerative Disease Research at AAN 2025
去年
SparX Biopharmaceutical and Mitsubishi Tanabe Pharma America Partner on Novel Immune Cell-Targeting ADC Program
9个月前
Shionogi Acquires RADICAVA Business from Tanabe Pharma for $2.5 Billion to Strengthen Rare Disease Portfolio
去年
Mitsubishi Tanabe Pharma America Presents ND0612 Data for Parkinson's Disease at PSG Meeting
11个月前
Mitsubishi Tanabe Pharma to Present Phase 3 Data on Continuous Levodopa Infusion ND0612 for Parkinson's Disease
去年
Mitsubishi Tanabe Pharma America Presents Real-World Data on RADICAVA ORS® for ALS at NASP 2024
去年
ND0612 Shows Sustained Efficacy in Parkinson's Disease Motor Fluctuations
去年
Spinal Cord Injury Treatment Market Poised for Growth with Emerging Therapies
去年
Edaravone Shows Promise in Targeting TDP-43 Mislocalization in ALS, New Preclinical Research Reveals
去年
Real-World Data Analysis Shows Edaravone Associated with Longer Milestone-Free Time in ALS
第 1 页,共 465 页
上一页
下一页